Latest News

Press Release

Product Search

Quick Link

Latest News

Home > Press Release > Latest News


18	Hanmi receives IR52 Jang Young-Shil Award from KOITA	03, Sep. 2010
17	Hanmi initiates the clinical trials of Amosartan in Europe	23, Aug. 2010
16	Hanmi ranks 1st in R&D investment among Korean pharmaceutical companies	16, Aug. 2010
15	European In Patient Study for Monthly GLP-1 class Type 2 Diabetes Drug	02, Aug. 2010
14	Amosartan Produces Good Newses	29, Jul. 2010
13	Amosartan, The 1st approval as the initial therapy among CCB+ARB hypertension Combo Drugs	08, Jul. 2010
12	Phase 1 underway for Atorvastatin plus Aspirin fixed dose combination drug	19, May. 2010
11	Hanmi pharmaceuticals to be exempted from drug price cut for 5 years	12, May. 2010
10	Nikkei reports the presentation of Hanmi at a JPLA meeting	30, Apr. 2010
9	LAPSCOVERY Platform Technology obtains US Patents	29, Apr. 2010
8	Hanmi submits IMPD in Europe for phase I clinical trials of LAPS-Exendin	27, Apr. 2010
7	Beijing Hanmi, High-tech Industry Certification	08, Apr. 2010
6	Most Prescribed Hypertension combo drug in Korea?	25, Mar. 2010
5	Hanmi wins the best drug research award of KDRA	04, Mar. 2010
4	Hanmi's Amosartan ranked the highest for detailing drugs	22, Feb. 2010
3	Hanmi to make Medicine Donation for Haiti	05, Feb. 2010
2	IND Application for long-acting Human Growth Hormone Approved	01, Feb. 2010
1	KFDA Approves IND Application of Once Monthly Exendin4 analog	12, Jan. 2010

45 Bangi-dong. Songpa. Seoul 138-724 Korea Tel 82. 2. 410. 9114
Copyright (c) 2004 by Hanmi Pham Co Ltd. All rights reserved